FDA — authorised 13 July 1950
- Application: NDA007513
- Marketing authorisation holder: HOSPIRA
- Local brand name: LEVOPHED
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Norepinephrine 10 mcg on 13 July 1950
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 13 July 1950; FDA has authorised it.
HOSPIRA holds the US marketing authorisation.